Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Lessons learned from troubles with COX-2 inhibitors

One of the nation’s leading cardiovascular medical researchers has issued a call for less aggressive direct-to-consumer advertising and better safety assurances of medications in a special article posted online by JAMA because of its relevance to the recent withdrawals and warning labels on the pain-relieving drugs known as COX-2 inhibitors.

28 Dec 2004

Spinal cord injury and obesity

Researchers at the University of Michigan Health System are looking at how people with spinal cord injury burn calories and how that is affected by their muscle mass and body weight. The goal is to make better recommendations to people with spinal cord injury, but the research will also translate into greater understanding of obesity in the general population as well.

26 Dec 2004

Tasty polymeal cuts heart disease by 76 per cent

A combined meal of seven foods including wine and chocolate could reduce cardiovascular disease by 76 per cent, a team of researchers has found.

21 Dec 2004

Out-of-office blood pressure readings help predict CVD risk

Blood pressure readings taken at home with approved devices can be a useful addition to blood pressure management, and may even predict cardiovascular disease (CVD) risk better than readings from the doctor’s office alone, according to a scientific statement issued today by the American Heart Association.

21 Dec 2004

Aspirin overlooked as an effective and inexpensive means to reduce cardiovascular disease risk in diabetic women and young adults

Cardiovascular disease risk is extremely high in adults with diabetes. Yet women as well as people under 50 who have diabetes do not use aspirin, despite the fact that aspirin has been found an effective and inexpensive means to reduce risk of first and subsequent heart attack.

20 Dec 2004

Potential safety risks with Celebrex

The Australian Therapeutic Goods Administration (TGA) has consulted today with the Chairs of its peak advisory committees, the Australian Adverse Drug Reactions Committee (ADRAC) and the Australian Drug Evaluation Committee (ADEC), about the latest research into the safety of the arthritis drug, Celebrex.

20 Dec 2004

Wine, fish, dark chocolate, fruits and vegetables cut the risk of heart disease

Scientists in this week's Christmas issue of the BMJ have discovered the 'Polymeal', a set of ingredients which cuts the risk of heart (cardiovascular) disease by 76% and significantly increases life expectancy.

20 Dec 2004

Celebrex suspension

The National Institutes of Health (NIH) announced that it has suspended the use of COX-2 inhibitor celecoxib (Celebrex™ Pfizer, Inc.) for all participants in a large colorectal cancer prevention clinical trial conducted by the National Cancer Institute (NCI).

19 Dec 2004

Low-dose diuretic therapy for most patients with hypertension recommended

Patients with high blood pressure who take calcium channel blockers and diuretics have an increased risk for cardiovascular disease (CVD) death compared to patients who take beta-blockers plus diuretics, according to a study in the current issue of JAMA.

16 Dec 2004

Race may play an important role in determining a person's obesity and fitness levels

Race may play an important role in determining a person's obesity and fitness levels, shows a new study in the December issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP).

13 Dec 2004

Ads for full-body scans to detect potential diseases, called into question

A burgeoning industry that sells full-body scans to detect potential diseases - without a doctor's referral - is running advertisements that frequently include unsubstantiated claims about the benefits of getting CT and MRI scans, while rarely providing information about the technology's limitations and risks.

13 Dec 2004

Obesity rate among American workers of all ages grew from 20% to 29% over the past decade

The obesity rate among American workers of all ages grew from 20% to 29% over the past decade, leading to serious repercussions in the workplace and a demand for solutions, according to a new Pfizer Inc study published today in the Journal of Occupational and Environmental Medicine.

13 Dec 2004

Folate supplementation during pregnancy may increase a mother's long-term risk of breast cancer

Preliminary data published in the BMJ suggest that folate supplementation during pregnancy may increase a mother's long-term risk of breast cancer. Although this may be a chance finding, the results require confirmation, say the authors.

13 Dec 2004

Cardiovascular experts issue blueprint for safer X-Ray imaging

Millions of invasive cardiovascular procedures that involve the use of potentially hazardous X-rays are done in the United States each year.

8 Dec 2004

Defect in one of nature's oldest proteins may be an underlying cause in human miscarriages

University of Rochester scientists studying a vital protein called Serum Response Factor (SRF) in mice have learned new and unexpected facts about SRF's role in early cardiovascular development, and how a defect in this gene may be an underlying cause in human miscarriages.

8 Dec 2004

Children are more vulnerable than adults to the adverse effects of air pollution

Children are more vulnerable than adults to the adverse effects of air pollution for several reasons. First, children have increased exposure to many air pollutants because they spend more time outside, have higher breathing rates and higher levels of physical activity compared with adults.

7 Dec 2004

New insight into anticoagulation therapies

Anticoagulation therapies, or treatments that reduce the amount of clotting factors in the blood, are quite common and used for a variety of reasons.

6 Dec 2004

Adenosine Therapeutics awarded grant to develop drug eluting stents to prevent restenosis

Adenosine Therapeutics announced today the award of a Phase II Small Business Innovation Research (SBIR) grant from the National Institutes of Health.

6 Dec 2004

Heart Hospital begins experimental cell therapy

Physicians at the Heart Hospital became the first team in the UK to treat a patient with an experimental new therapy designed to repair damage to cardiac muscle resulting from a heart attack. If successful, this treatment would give doctors the ability to improve the hearts of people with heart failure, rather than just treating the symptoms.

6 Dec 2004

New poll shows one in five Americans may stop using vitamin E, experts concerned

A new national poll demonstrates that 18 percent of Americans are less likely to take vitamin E based on the news suggesting high doses "may increase risk of dying" among older, high-risk patients.

3 Dec 2004

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Lessons learned from troubles with COX-2 inhibitors

Spinal cord injury and obesity

Tasty polymeal cuts heart disease by 76 per cent

Out-of-office blood pressure readings help predict CVD risk

Aspirin overlooked as an effective and inexpensive means to reduce cardiovascular disease risk in diabetic women and young adults

Potential safety risks with Celebrex

Wine, fish, dark chocolate, fruits and vegetables cut the risk of heart disease

Celebrex suspension

Low-dose diuretic therapy for most patients with hypertension recommended

Race may play an important role in determining a person's obesity and fitness levels

Ads for full-body scans to detect potential diseases, called into question

Obesity rate among American workers of all ages grew from 20% to 29% over the past decade

Folate supplementation during pregnancy may increase a mother's long-term risk of breast cancer

Cardiovascular experts issue blueprint for safer X-Ray imaging

Defect in one of nature's oldest proteins may be an underlying cause in human miscarriages

Children are more vulnerable than adults to the adverse effects of air pollution

New insight into anticoagulation therapies

Adenosine Therapeutics awarded grant to develop drug eluting stents to prevent restenosis

Heart Hospital begins experimental cell therapy

New poll shows one in five Americans may stop using vitamin E, experts concerned

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in